Detalles de la búsqueda
1.
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
J Infect Dis
; 213(12): 1946-54, 2016 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26908741
2.
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
Clin Infect Dis
; 35(5): 611-7, 2002 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12173138
3.
Detection of mucosal antibodies in HIV type 1-infected individuals.
AIDS Res Hum Retroviruses
; 18(17): 1291-300, 2002 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-12487817
4.
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
Vaccine
; 30(10): 1830-40, 2012 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234262
5.
Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.
PLoS One
; 5(11): e13849, 2010 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21079762
6.
Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Glycobiology
; 15(10): 994-1001, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15917430
7.
Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens.
J Biol Chem
; 280(32): 28959-65, 2005 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15955803
8.
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
J Virol
; 79(6): 3358-69, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15731230
9.
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
J Virol
; 79(2): 771-9, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613305
10.
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein.
Immunol Cell Biol
; 82(5): 523-30, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15479438
11.
Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
Immunol Cell Biol
; 82(5): 531-8, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15479439
12.
Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.
J Infect Dis
; 186(8): 1173-6, 2002 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12355371
13.
Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.
J Clin Microbiol
; 41(5): 2153-5, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12734265
14.
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
J Virol
; 77(19): 10348-56, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12970419
Resultados
1 -
14
de 14
1
Próxima >
>>